Search Results

Association between major depressive disorder or depressive symptoms and the risk of vascular complications among patients with type 2 diabetes, and the mediating role of metabolic biomarkers: an analysis of the UK Biobank cohort.

• Authors : Li, Guochen; Yu, Yongfu; Lin, Chunqing

Subjects: Depressive symptoms; Major depressive disorder; Mediator metabolites

Record details

Genetic insights into psychotic major depressive disorder: bridging the mood-psychotic disorder spectrum

• Authors : Nguyen, Thuy-Dung; Meijsen, Joeri J.; Sigström, Robert

Subjects: Epidemiology; Genetic; Psychotic disorders

• Source: EBioMedicine. 112

Record details

Validating the On-line Creyos Cognitive Assessment Platform in Older Adults With Major Depressive Disorder or Mild Cognitive Impairment (Creyos-MD)

• Authors : Krembil Foundation;

• Source: Validating the On-line Creyos Cognitive Assessment Platform in Older Adults With Major Depressive Disorder or Mild Cognitive Impairment

Record details

Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD) (MDD)

• Authors : University of Toronto; Centre for Addiction and Mental Health; Toronto Metropolitan University

• Source: Lemborexant for the Treatment of Residual Insomnia in Adequately Treated Major Depressive Disorder: a Pilot Randomized Controlled Trial

Record details

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure (INTENSIFY)

• Authors : Universität Münster; Dr. Inge Winter, Workpackage leader

• Source: A Randomised, Controlled Trial to Investigate the Effect of an Intensified Pharmacological Treatment for Schizophrenia, Major Depressive

Record details

The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. (INTENSIFY MDD)

• Authors : Universität Münster; Dr. Inge Winter, Principal Investigator

• Source: A Randomised, Controlled Trial to Investigate the Effect of a Sixweek Intensified Pharmacological Treatment for Major Depressive Disorder

Record details

NMDA Modulation in Major Depressive Disorder

• Authors : Ministry of Science and Technology, Taiwan

• Source: NMDA Modulation in Major Depressive Disorder

Record details

NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder

• Source: NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder

Record details

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder (ESCAPE-TRD)

• Source: A Randomized, Open-label, Rater-Blinded, Active-Controlled, International, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Flexibly Dosed Esketamine Nasal Spray Compared With

Record details

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

• Source: A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and

Record details